Introduction {#s0005}
============

Voltage-gated calcium (Ca~V~) channels consist of three subgroups, the Ca~V~1, 2 and 3 classes ([@b0090]). Most of these channels, apart from Ca~V~1.1 which is a skeletal muscle channel, are involved in neuronal function, with their most prevalent functions being in excitation--transcription coupling (Ca~V~1.2), synaptic transmission (Ca~V~2 channels), and regulation of neuronal excitability and pacemaker activity (Ca~V~3 channels). Because of their key roles in neuronal function, it is not surprising that a number of different calcium channels have been implicated in the pathogenesis of various forms of epilepsy, in both humans and in animal models. These channels include T-type (Ca~V~3) channels ([@b0395; @b0440; @b0100]), P/Q-type (Ca~V~2.1) channels ([@b0210; @b0355]), and the auxiliary subunits, β4 ([@b0160]) and α~2~δ-2 ([@b0020; @b0150]). Furthermore several calcium channels are either actual or potential targets for therapeutic intervention ([@b0075; @b0350]).

The Ca~V~ auxiliary α~2~δ and β subunits, both of which have four isoforms, are associated with the "high voltage activated" Ca~V~1 (L-type) and Ca~V~2 classes (N, P/Q and R-type) of calcium channel, but are not thought to be associated with Ca~V~3 (T-type) calcium channels. Both auxiliary subunits increase plasma membrane expression of the Ca~V~1 and Ca~V~2 channels, and influence their biophysical properties ([@b0135]). Of relevance to the potential pathological roles of α~2~δ subunits, the α~2~δ-1 isoform is up-regulated following peripheral somatosensory nerve damage (for review see [@b0030]), whereas mutations in α~2~δ-2 have been linked to absence epilepsy ([@b0020; @b0130; @b0150]). The α~2~δ proteins have also been reported to fulfill other functions independent of calcium channels ([@b0155; @b0245]), and are likely to interact with other binding partners, including thrombospondins ([@b0155]).

Both α~2~δ-1 and α~2~δ-2 represent binding sites for the anti-epileptic α~2~δ ligand drugs gabapentin and pregabalin ([@b0055; @b0240]). These drugs are used as adjunct therapy in several forms of epilepsy, particularly drug-resistant partial seizures ([@b0300; @b0010; @b0415]). They are also widely used in the treatment of neuropathic pain resulting from peripheral nerve damage of various origins, such as trauma, trigeminal neuralgia, diabetes-induced nerve damage, and chronic pain following viral infection, including post-herpetic neuralgia ([@b0315; @b0320]). They have also been used for alleviation of chronic pain resulting both from human immunodeficiency virus (HIV) infection and as a side effect of some of the anti-HIV drugs ([@b0370]). Chronic neuropathic pain resulting from cancer chemotherapeutic drugs, including paclitaxel and cisplatin, is also treated with gabapentinoid drugs ([@b0165]).

The mechanism of action of the gabapentinoid drugs in the treatment of epilepsies remains unclear. In this study we wished to examine whether the level or distribution of α~2~δ-1 was altered following experimental induction of epileptic seizures in rats, since a change in α~2~δ-1 level or distribution might contribute to the anti-epileptic mechanism of action of gabapentinoid drugs, in a similar way to their therapeutic action in neuropathic pain (see Discussion). It was not possible to examine changes in distribution of α~2~δ-2 protein in parallel in this study, as no antibodies suitable for immunohistochemistry are currently available.

We chose to use the rat kainic acid model of human temporal lobe epilepsy, in which spontaneous seizures have been found to occur following a latent period after the initial induction by kainic acid of persistent seizures, known as status epilepticus ([@b0070]). In this model, rats first develop status epilepticus, and then consistently develop spontaneous seizures which exhibit a gradual increase in spontaneous frequency in the subsequent weeks ([@b0145]). This model is relevant because gabapentin is known to be effective against seizures induced by this means ([@b0110]). For comparison, we also used the tetanus toxin model of temporal lobe epilepsy ([@b0220]), in which status epilepticus is not induced ([@b0175]).

Experimental procedures {#s0010}
=======================

Kainic acid treatment {#s0015}
---------------------

Ten adult male Sprague--Dawley rats weighing approximately 250 g were injected with kainic acid (2.5 mg/kg i.p.) to induce status epilepticus. Injections were repeated once per hour until 5--9 Racine stage III/IV/V seizures per hour have occurred ([@b0290]). After 40--60 min from the onset of status epilepticus (near-continuous motor epileptic activity), diazepam (10 mg/kg, i.p.) was injected repeatedly until continuous motor activity disappeared. Following status epilepticus animals were housed separately. When seizures stopped, diazepam (2.5 mg/kg, i.p.) was continued every 30 min. Subcutaneous administration of warmed sterile saline was given if the animals appeared lethargic and/or a significant drop in weight occurred. Rats were housed in single cages under standard conditions in a room with controlled temperature (22 ± 1 °C) and 12/12-h light/dark cycle. The animals had *ad libitum* access to food and water. Immediately following the status epilepticus, rats were manually fed, if necessary until adequate recovery, and provided with standard food and also mashed food and apple slices. Control animals were treated with an equivalent volume and number of injections of sterile saline.

Unilateral intrahippocampal injection of tetanus toxin {#s0020}
------------------------------------------------------

Four rats were injected with tetanus toxin and four rats with saline as controls. Surgical preparation was performed as previously described ([@b0235]), under ketamine/xylazine anesthesia. A small trephine opening was drilled over the right hippocampus at coordinates 4.1 mm caudal to bregma and 3.9 mm laterally ([@b0335]). Using a Hamilton microsyringe and infusion pump (KD Scientific Inc., Holliston, USA) 1 μl of tetanus toxin (Sigma--Aldrich, Poole, UK) solution was injected into the stratum radiatum of the right hippocampal CA3 area (depth 3.9 mm). The tetanus toxin solution contained 25 ng of tetanus toxin in 1 μl of 0.05 M phosphate-buffered saline (PBS; Sigma--Aldrich, UK) and 2% bovine serum albumin (Sigma--Aldrich, UK). It was injected at 200 nl/min. The microsyringe was left in the hippocampus for 5 min after the injection ended to avoid the solution leaking back through the injection track. Control animals were injected with 1 μl of 0.05 M PBS with 2% bovine serum albumin. Following surgery, the rats were housed in single cages and allowed to recover for 2 days. Subsequently they were monitored for spontaneous seizures in video monitoring units to verify the development of spontaneous and recurrent seizures. Videos were recorded using digital infra-red cameras (Y-cam Solutions Ltd., Richmond, UK). Animals were video-monitored for 4 weeks.

All animal procedures were licensed and performed in strict accordance with the Animal Scientific Procedures Act (1986) of the United Kingdom and with Birmingham University Ethical Review.

Sample preparation and immunohistochemistry {#s0025}
-------------------------------------------

Rats were deeply anesthetized with an intraperitoneal injection of (600 mg/kg) pentobarbitone (Euthatal, Merial Animal Health, Harlow, UK), perfused transcardially with saline containing heparin, followed by perfusion with 4% paraformaldehyde in 0.1 M phosphate buffer (PB, pH 7.4). Brains were dissected and the tissue was post-fixed for 1.5--2 h, washed with PB, cryoprotected by incubation in PB with 15% sucrose, and finally frozen before embedding in optical cutting temperature compound (OCT) and sectioning with a cryostat. Serial coronal sections of 25 μm of the brain region including the hippocampus were collected and placed sequentially on a series of six slides, with 4 sections/slide; the distance between each section and the next on any slide was therefore 150 μm. A total of at least eight such series were collected per animal.

For Cresyl Violet staining, the first slide of each series was consecutively immersed for 5 min in PBS, 50%, and 75% ethanol (EtOH) and then stained in 0.1% Cresyl Violet (Sigma) for 15 min; after washing in H~2~O, the slides were briefly immersed in 75% EtOH, 0.3% acetic acid, dehydrated, cleared in Histoclear for 5 min and mounted in DPX, neutral mounting medium (Sigma--Aldrich).

For immunofluorescence labeling to detect α~2~δ-1, sections underwent heat-induced antigen retrieval (10 mM citrate buffer, pH 6.0, 0.05% Tween 20, 98 °C for 10 min) prior to blocking with 10% goat serum in the presence of 0.1% Triton X-100 in PBS for 1 h. Sections were then incubated with the mouse monoclonal anti-α~2~-1 antibody (Sigma, 1:100) in 50% blocking buffer for 2 or 3 days at 4 °C. These sections were also stained for microtubule-associated protein-2 (chicken Ab against MAP2, EnCor Biotechnology, Gainesville, FL, 1:1000). After extensive washing with PBS containing 0.1% Triton X-100, sections were incubated with biotinylated goat anti-mouse IgG (1:500) overnight at 4 °C and Streptavidin--Alexa Fluor 488 (1:500) and goat anti-chicken ab coupled to Alexa Fluor 647 (1:500) overnight at 4 °C. Samples processed for NeuN immunoreactivity (mouse monoclonal NeuN Ab, Millipore, 1:500) and OX42 immunoreactivity (mouse monoclonal OX42 Ab, Abcam, 1:200) were treated in the same way except that they did not require antigen retrieval. Samples were then washed and all were stained with 4′,6-Diamidino-2-Phenylindole (DAPI), before mounting in VectaShield (Vector Laboratories, Burlingame, CA, USA).

In the kainic acid study, experiments were performed on a total of 16 rats (10 kainate-treated and six saline-treated, [Table 1](#t0005){ref-type="table"}), of which all were analyzed for histological abnormalities in the hippocampus by staining the first slide of each series with Cresyl Violet. This staining was therefore performed on at least 8 slides per animal. Slides from 10 kainate-treated rats and four saline-treated were stained for α~2~δ-1 and MAP2 immunoreactivity, selecting one slide from each of 2--3 series adjacent to those showing neuronal cell disruption from the Cresyl Violet staining. Adjacent slides were then processed for NeuN and OX42 staining (one slide each from one representative series per animal; from six kainate-treated and three saline-treated rats). In the tetanus toxin study, four tetanus toxin-injected and four saline-injected rats were processed similarly ([Table 2](#t0010){ref-type="table"}).

Image acquisition and analysis and composite assembly {#s0030}
-----------------------------------------------------

Cresyl Violet staining was visualized on a Leica MZ7.5 stereomicroscope with a DC300 camera under transmitted light using the Leica IM50 software (Leica, Milton Keynes, UK). To produce the hippocampus composites immunofluorescence images were acquired with Volocity using an inverted fluorescence microscope Axiovert 500 M with a 5× objective, converted to JPEGs and mounted using Autostich software ([www.autostich.net](http://www.autostich.net){#ir0005}), or manually if the level of signal was too low for the software. For higher resolution, confocal images were acquired in a Zeiss LSM 500 M with a 10× objective (15 μm optical sections) using Zeiss LSM Image acquisition software.

Spinal nerve ligation (SNL) experiments {#s0035}
---------------------------------------

These data were obtained during the course of a previous study ([@b0025]), but the images in [Fig. 6](#f0030){ref-type="fig"} were not included in that study. All the experimental detail is identical to that previously described ([@b0025]).

Results {#s0040}
=======

Gross morphology and cell loss in the hippocampus following kainic acid treatment {#s0045}
---------------------------------------------------------------------------------

Rats were repeatedly injected with kainic acid (2.5 mg/kg, i.p., *n* = 10), until status epilepticus was observed, which occurred in 8/10 kainic acid-treated rats ([Table 1](#t0005){ref-type="table"}). For the control rats, saline was administered (*n* = 6; [Table 1](#t0005){ref-type="table"}). Rats were then perfused and the brains removed after 5 weeks.

The gross morphology of all the hippocampi was examined with Cresyl Violet staining, in order to determine whether neuronal cell death had occurred. Immunostaining was then performed for α~2~δ-1 and the dendritic marker MAP2 in all 10 kainic acid-treated and four of the saline-treated rats. In six kainate-treated and three saline-treated rats, immunostaining was also performed for the microglial marker OX-42 ([@b0385]) and the neuronal nuclear marker NeuN.

We were interested in whether kainate-induced seizures and neuronal damage were associated with an altered expression of α~2~δ-1. From an examination of gross morphology using Cresyl Violet staining, we found regions of neuronal cell loss in CA1, CA3 and the hilus of the dentate gyrus in 8/8 kainate-treated animals which had developed status epilepticus ([Fig. 1](#f0005){ref-type="fig"}A, arrows; [Table 1](#t0005){ref-type="table"}), and 1/2 kainate-treated rats which did not develop status epilepticus ([Table 1](#t0005){ref-type="table"}), but not in any saline-treated rats ([Fig. 1](#f0005){ref-type="fig"}B and [Table 1](#t0005){ref-type="table"}). This neuronal cell loss was confirmed by comparing NeuN immunostaining, which stains neuronal nuclei ([Fig. 1](#f0005){ref-type="fig"}C, D), with DAPI staining ([Fig. 1](#f0005){ref-type="fig"}E, F), which stains all nuclei.

Expression of OX42 in hippocampus following kainic acid treatment {#s0050}
-----------------------------------------------------------------

We found that expression of OX42, a marker of microglial activation ([@b0360]), was present in the hippocampus of 4/4 kainate-treated rats examined that had experienced status epilepticus ([Fig. 1](#f0005){ref-type="fig"}G) and in 1/2 rats that did not develop status epilepticus. Expression of OX42 was seen in both CA1 and CA3 regions ([Fig. 1](#f0005){ref-type="fig"}G), as well as elsewhere in the brain (data not shown). The location of neuronal damage, determined by loss of NeuN staining was generally associated with the appearance of OX42 staining (compare [Fig. 1](#f0005){ref-type="fig"}C, G). In contrast, no OX42 staining was observed in 3/3 hippocampi examined of saline-treated controls or 1/2 kainate-treated rat that did not develop status epilepticus and did not show any brain damage ([Table 1](#t0005){ref-type="table"} and [Fig. 1](#f0005){ref-type="fig"}H).

Expression of α~2~δ-1 in hippocampus following kainic acid treatment {#s0055}
--------------------------------------------------------------------

The α~2~δ-1 subunit has been identified previously as a synaptic protein, present particularly in presynaptic terminals ([@b0420; @b0025]). However, α~2~δ-1 is also associated with calcium channels, including L-type calcium channels, present on dendrites ([@b0365]). We found α~2~δ-1 to be expressed throughout the hippocampus ([Fig. 2](#f0010){ref-type="fig"}) although largely absent from the main cell body layers, including the granule cells of the dentate gyrus, and the CA3 and CA1 pyramidal cell layers. The α~2~δ-1 protein is particularly strongly expressed in the molecular layer and hilus of the dentate gyrus and in the CA3 stratum lucidum, but also in the stratum oriens and stratum radiatum of the CA1 region ([Fig. 2](#f0010){ref-type="fig"}A). This distribution is similar to that found previously using paraffin-embedded rat brain sections and Horseradish Peroxidase staining ([@b0420]).

Since α~2~δ-1 is elevated following peripheral nerve damage in both sensory neurons ([@b0285; @b0325; @b0025]) and in motor neurons ([@b0025]; see also [Fig. 6](#f0030){ref-type="fig"}), we examined whether α~2~δ-1 expression was altered in the hippocampus of kainate-treated rats. We did not observe any consistent increase of α2δ-1 staining in any region of the hippocampus of any of the kainate-treated rats; on the contrary there was localized loss of α~2~δ-1 immunostaining in the CA1 region, occurring in patches ([Fig. 2](#f0010){ref-type="fig"}B, left panels, arrows), at sites correlating with CA1 pyramidal neuronal cell loss, shown by NeuN staining ([Fig. 2](#f0010){ref-type="fig"}B, upper right panel, arrow). These patches are also associated with regions of reactive gliosis, indicated by OX42 staining ([Fig. 2](#f0010){ref-type="fig"}B, lower right panel, arrow).

At higher power magnification ([Fig. 3](#f0015){ref-type="fig"}), the patches associated with loss of α~2~δ-1 immunoreactivity are also associated with a reduction in MAP-2 staining, indicative of a loss of pyramidal cell dendrites, and an increase in DAPI staining, likely to be associated with reactive gliosis (starred areas in [Fig. 3](#f0015){ref-type="fig"}A). In [Fig. 3](#f0015){ref-type="fig"}B, a region from the same hippocampus, 1.2 mm rostral to the damaged area, is shown as a control.

Despite extensive pyramidal neuron loss from the CA3 region, in the tissue from 9/10 kainic acid-treated rats ([Figs. 1](#f0005){ref-type="fig"}A, C, E, [2](#f0010){ref-type="fig"}B, [3](#f0015){ref-type="fig"}A and [4](#f0020){ref-type="fig"}A), we found that the strong α~2~δ-1 immunostaining in the CA3 stratum lucidum was undiminished in these hippocampi ([Fig. 4](#f0020){ref-type="fig"}). In [Fig. 4](#f0020){ref-type="fig"}Ai and ii, the CA3 regions from two kainate-treated rats are shown in comparison with the same region from a saline-treated rat ([Fig. 4](#f0020){ref-type="fig"}B). The CA3 stratum lucidum showing intense α~2~δ-1 staining corresponds to the layer containing mossy fiber terminal synapses. In some sections, expression of α~2~δ-1 was also observed to be associated with the stratum oriens of the CA3 region in kainate-treated rats ([Fig. 4](#f0020){ref-type="fig"}Ai). This was observed in 3/10 kainate-treated rats ([Table 1](#t0005){ref-type="table"}), but we also observed strong α~2~δ-1 staining in the stratum oriens of one of the saline-treated rats ([Table 1](#t0005){ref-type="table"}).

Effect of intrahippocampal tetanus toxin on OX42 and α~2~δ-1 staining {#s0060}
---------------------------------------------------------------------

For comparison with the kainic acid model, we examined four rats given an intra-hippocampal injection of tetanus toxin, with four rats given saline injection as controls. Three of the tetanus toxin-treated animals developed spontaneous seizures ([Table 1](#t0005){ref-type="table"}). None of the saline-treated rats developed seizures.

Hippocampal sections from all rats were subjected to immunohistochemical analysis of α~2~δ-1 and OX42 immunoreactivity, and counterstained with DAPI. The pattern of expression of α~2~δ-1 did not show any significant change in any of the samples, except a localized reduction of immunoreactivity in CA1, coinciding with the injection track in two of the tetanus toxin-treated rats ([Fig. 5](#f0025){ref-type="fig"}A, top and middle panels, arrowed), and one saline-treated rat (data not shown). OX42 signal also appeared along the injection track in all the tetanus toxin-treated ([Fig. 5](#f0025){ref-type="fig"}A, bottom panel, arrow) and 3/4 saline-treated rats ([Fig. 5](#f0025){ref-type="fig"}B left panel). A minor contralateral expression of OX42 in CA1 stratum pyramidale was observed in one of the four tetanus toxin-treated rats that developed late seizures ([Fig. 5](#f0025){ref-type="fig"}A, bottom panel, arrowheads). DAPI staining revealed that in all cases, there was some cell loss in the CA1 stratum pyramidale and/or lateral dentate gyrus, associated with the injection track ([Fig. 5](#f0025){ref-type="fig"}A middle panel and 5B right panel), and this neuronal cell death coincided with the areas showing OX42 immunoreactivity and reduced α~2~δ-1.

Up-regulation of α~2~δ-1 following peripheral nerve injury {#s0065}
----------------------------------------------------------

In contrast to the results described above, following physical insult to peripheral axons of somatosensory nerves, such as SNL ([Fig. 6](#f0030){ref-type="fig"}A) and partial sciatic nerve ligation (PSNL), α~2~δ-1 mRNA and protein is rapidly and strongly up-regulated on the injured side in dorsal root ganglion (DRG) neuron somata ([Fig. 6](#f0030){ref-type="fig"}B compared to [6](#f0030){ref-type="fig"}C), axons ([Fig. 6](#f0030){ref-type="fig"}D compared to [6](#f0030){ref-type="fig"}E) and terminals ([Fig. 6](#f0030){ref-type="fig"}F), as previously described ([@b0325; @b0260; @b0025; @b0330]). This finding represents an aspect of the well-studied and poorly understood difference between injury-induced regeneration in peripheral and central neurons ([@b0430; @b0105]). Importantly, we found that α~2~δ-1 was also up-regulated in motor neurons following SNL, likely to be a consequence of their axonal damage caused by the ligation ([@b0025]) ([Fig. 6](#f0030){ref-type="fig"}F, G, H).

Discussion {#s0070}
==========

Altered expression of hippocampal α~2~δ-1 following kainic acid-induced status epilepticus {#s0075}
------------------------------------------------------------------------------------------

Many molecular changes have been described in chronic epileptic tissue. Furthermore, several types of channelopathies were identified in neurons from chronic models of acquired epilepsy. They involve alterations of kinetics of voltage-gated channels, changes in subunit composition, expression of new types of channels or abnormalities of subcellular distribution of specific channels ([@b0345]). Channelopathies affecting sodium, potassium ([@b0035]), calcium ([@b0395]) or I~h~ ([@b0380]) channels have been described. These alterations represent molecular, structural and functional changes which occur during epileptogenesis and are responsible for increased cellular excitability, altered functional properties of dendrites and conversion from regular firing neurons to bursting neurons. Furthermore, up-regulation of T-type calcium currents was demonstrated in apical dendrites of CA1 neurons following the pilocarpine status epilepticus ([@b0395]).

The present results indicate that damage to the central nervous system by kainic acid treatment, which provokes status epilepticus, followed by delayed development of spontaneous seizures in rats ([@b0070]), does not result in a widespread up-regulation of α~2~δ-1 in the hippocampus, at least not at 5 weeks post-kainic acid. Although no overall up-regulation of mossy fiber α~2~δ-1 was observed at the time of this analysis, a reduction of α~2~δ-1 was observed in regions of CA1 pyramidal cell loss. These results may indicate that in the regions of kainate-induced CA1 pyramidal cell loss, the α~2~δ-1 protein associated with presynaptic Ca~V~ channels, in the *en passant* synapses from CA3 neurons or Schaffer collaterals onto CA1 pyramidal neurons, is redistributed once the target CA1 cells and their dendrites are lost (see Figs. [2](#f0010){ref-type="fig"}B and [3](#f0015){ref-type="fig"}A). This may therefore represent a local up-regulation of α~2~δ-1 at neighboring synapses, although to examine this in the future will require quantitative analysis at the electron microscopic level. This increased presynaptic α~2~δ-1 localization could have increased transmitter release as a consequence ([@b0205]).

Axonal sprouting of mossy fibers has been found to occur after kainate treatment ([@b0310]). Possible ectopic expression of α~2~δ-1 was observed in the stratum oriens of the CA3 region of some kainate-treated rats that could be associated with mossy fiber sprouting (see [Fig. 4](#f0020){ref-type="fig"}Ai), but there was no up-regulation of α~2~δ-1 protein in cell body regions in the dentate gyrus, unlike the situation following peripheral nerve damage.

OX42 up-regulation provides evidence of microglial activation, and has been shown to be an early response to brain injury, including kainate-induced lesions ([@b0005]). In the present study we found widespread bilateral microglial activation following kainic acid administration, in all the rats examined that showed status epilepticus, and in one of two rats that did not demonstrate status epilepticus.

Comparison of histological changes observed in the kainic acid and tetanus toxin-induced seizure models {#s0080}
-------------------------------------------------------------------------------------------------------

The hippocampi of rats injected with tetanus toxin only showed localized lesions that mainly coincided with the injection track, and correspondingly localized development of OX42 staining. However, three out of four of these rats developed spontaneous seizures. When compared with the kainate model and other status epilepticus models, the tetanus toxin model possesses distinct features. Tetanus toxin is known to induce chronic epilepsy with spontaneous and recurrent seizures but without morphological changes, and in particular without initial status epilepticus ([@b0235]). It was shown previously that hippocampal sclerosis characterized by major cell loss was present in only 10% of animals and affected mainly the CA1 region ([@b0215; @b0450; @b0230; @b0235]). Selective loss of somatostatin-positive interneurons has been demonstrated 8 weeks following tetanus toxin injection ([@b0225]). One consistent structural change is axonal sprouting, both in the dentate gyrus (mossy fiber sprouting shown by Timm staining) and in the CA1 region. Based on the results obtained here, we can speculate that changes in α~2~δ-1 distribution observed in the kainate model can be attributed to status epilepticus and/or associated neuronal cell loss.

α~2~δ-1 up-regulation is a marker of peripheral nerve injury {#s0085}
------------------------------------------------------------

The α~2~δ-1 subunit is expressed in primary afferent DRG neurons, and is particularly strongly expressed in small DRG neurons, which include C-fiber nociceptors ([@b0025]). *Cacna2d1*, encoding α~2~δ-1, is one of many genes whose expression is altered following experimental peripheral nerve damage. Indeed, α~2~δ-1 mRNA and protein shows up-regulation following several different types of damage to peripheral axons of DRG neurons, including ligation, chemotherapy and diabetes-induced neuropathy ([@b0285; @b0280; @b0325; @b0125; @b0305; @b0455; @b0025]). Furthermore we have found an alteration in α~2~δ-1 splice variant expression in DRGs following peripheral nerve damage ([@b0250]).

The mechanism(s) involved in alteration of gene expression following somatosensory nerve damage are thought to involve propagation of an axonal injury-induced Ca^2+^ wave to the DRG soma, resulting in histone deacetylase 5 export from the nucleus, and activation of gene transcription, a process which has been found to occur in damaged peripheral but not central neurons ([@b0105]).

Comparison of changes in α~2~δ-1 observed in the models of epilepsy and neuropathic pain {#s0090}
----------------------------------------------------------------------------------------

A major difference between the peripheral somatosensory nerve damage that results in α~2~δ-1 up-regulation and kainate-induced neuronal damage is that in the latter there is loss of CNS neurons, in some cases accompanied by sprouting of neighboring neurons, whereas in the former situation, the DRG somata are not killed by the peripheral nerve insult, and the damaged peripheral axons can regenerate. However, although our results do not demonstrate overt or widespread up-regulation of α~2~δ-1 in hippocampal neuronal somata, it is possible that there has been redistribution of α~2~δ-1 at synaptic terminals in areas affected by neuronal cell loss.

Mechanism of action of gabapentinoid drugs in the alleviation of neuropathic pain {#s0095}
---------------------------------------------------------------------------------

The high affinity binding site for ^3^H-gabapentin in the brain was purified and identified to be α~2~δ-1 ([@b0180; @b0060]), and it was subsequently found to bind to α~2~δ-2 with similar affinity ([@b0295; @b0190]). Autoradiographic studies then identified α~2~δ-1 as the major binding site for ^3^H pregabalin in the rat cerebral cortex, hippocampus and other brain regions, although α~2~δ-2 represented the main binding site in the cerebellum and interpeduncular nucleus ([@b0040]).

We have recently shown that the up-regulation of α~2~δ-1 is required for the rapid development of mechanical hypersensitivity following PSNL, since this is markedly delayed in α~2~δ-1 knockout mice ([@b0330]). It is widely assumed that the up-regulation of α~2~δ-1 in damaged somatosensory neurons is related to the efficacy of the gabapentinoid drugs in alleviating neuropathic pain in humans as well as animal models, since the gabapentinoids are ineffective in mice lacking α~2~δ-1 ([@b0330]), and in knockin mice in which α~2~δ-1 is mutated so that it does not bind gabapentinoid drugs ([@b0170]). Nevertheless the mechanism of action of these drugs at the molecular level still remains unclear, as they are generally found to produce little acute inhibition of calcium currents or synaptic transmission ([@b0400; @b0065; @b0195]). However, some studies have found acute effects of these drugs on synaptic transmission ([@b0445]).

We have found that the α~2~δ-subunits enhance plasma membrane expression of calcium channels; although the mechanism still remains unclear, it is thought to involve trafficking of the channels from their site of synthesis to the plasma membrane ([@b0080; @b0030]). It is likely that in neurons α~2~δ subunits have multiple effects on calcium channel distribution, both associated with long-range calcium channel trafficking from their site of synthesis in the soma to their mainly presynaptic localization in nerve terminals ([@b0025]), and also local effects on calcium channel localization in membrane micro-domains such as the active zone and in lipid rafts ([@b0120; @b0205]), as well as influencing the recycling of calcium channels to the plasma membrane ([@b0435]).

Furthermore, we have found that the gabapentinoid drugs have an inhibitory effect on calcium currents when applied over longer time periods, in cultured cells and neurons ([@b0195; @b0435]), which we infer is by inhibiting the trafficking of the α~2~δ subunits ([@b0195; @b0030; @b0435]). We also observed *in vivo* that there was less up-regulation of α~2~δ-1 in nerve terminal zones, after the induction of somatosensory nerve injury when it was combined with chronic pregabalin treatment ([@b0025]), which might be an effect on long range axonal trafficking, or on lifetime of the protein and its local recycling at presynaptic terminals. Our evidence currently indicates that this interference by gabapentinoids with the function of α~2~δ-1 and α~2~δ-2 results in a reduction of expression of the entire calcium channel complex at the plasma membrane ([@b0435; @b0085]). In agreement with this, we have also observed inhibitory effects of chronically applied gabapentinoids on excitatory synaptic transmission from DRG neuron terminals ([@b0200]).

Role of α~2~δ subunits and mechanism of action of gabapentinoids in epilepsy {#s0100}
----------------------------------------------------------------------------

The gabapentinoid drugs have therapeutic efficacy as antiepileptic drugs, although they are generally used in combination therapy ([@b0300; @b0185]). In animal models of seizures, gabapentin has been shown to be effective ([@b0110]). However, the mechanism of action of the gabapentinoid drugs in epilepsy is poorly understood. Although both gabapentin and pregabalin were first developed to enhance GABA-ergic inhibition in the brain ([@b0425; @b0415; @b0390]), it is now clear that they do not act by mechanisms involving inhibition of GABA breakdown, or activation of GABA-A or GABA-B receptors ([@b0415; @b0270]). Furthermore GABA itself does not bind to the α~2~δ subunits that are now known to be the target for gabapentinoid drugs ([@b0270]).

Although it has been found that α~2~δ-1 is the target for the gabapentinoid drugs in the alleviation of experimental neuropathic pain in rodents, ([@b0170; @b0330]), this is not known for the efficacy of the gabapentinoids in animal models of epilepsy. An *in situ* hybridization study showed that α~2~δ-1 expression was often more associated with excitatory neurons, and α~2~δ-2 with inhibitory neurons ([@b0115]). The α~2~δ-1 protein is strongly expressed in the hippocampus, therefore it is possible that a change in expression of α~2~δ-1 in epileptic foci might influence the effectiveness of the gabapentinoid drugs. In contrast α~2~δ-2 is expressed in a more restricted pattern, for example it is strongly expressed in cerebellar Purkinje neurons ([@b0020; @b0050]). The loss of expression of α~2~δ-2 in *cacna2d2* mutant mouse strains including "Ducky" results in cerebellar ataxia and spike-wave epilepsy, and is associated with severe Purkinje cell dysfunction ([@b0020; @b0050; @b0045; @b0140]). Furthermore *CACNA2D2* is disrupted in rare recessive human cases of epileptic encephalopathy ([@b0150; @b0340]). Therefore interference with α~2~δ-2 function might be intuitively less likely to be the therapeutic target of the gabapentinoids in epilepsy, compared to disruption of α~2~δ-1 function. However, this would not exclude the possibility that there is localized alteration of α~2~δ-2 expression, which could be a therapeutic target in focal (partial) epilepsy.

Thus it is possible that α~2~δ-2 levels or distribution might be affected in animal models of epilepsy. Unfortunately there are currently no available α~2~δ-2 antibodies that are effective in immunohistochemistry, so at present this cannot be easily tested. However, it would be extremely useful to examine whether gabapentin is effective in epilepsy models, using knockin mice in which either α~2~δ-1 ([@b0170]) or α~2~δ-2 is mutated so that it is gabapentin-insensitive ([@b0275]).

Non-calcium channel functions of α~2~δ proteins {#s0105}
-----------------------------------------------

Recently, α~2~δ-1 has been found to interact with thrombospondins ([@b0155]), and this interaction has been shown to be involved in synaptogenesis, a process which has been described as being independent of its function as a calcium channel subunit. Thrombospondins are a ubiquitous family of extracellular matrix proteins, which are secreted by many cell types, including microglia ([@b0095; @b0155]). In a number of experimental and human epilepsies there is reactive gliosis ([@b0375]), microglial activation ([@b0015]), and axonal sprouting ([@b0410; @b0310; @b0450; @b0405]). It has also been proposed that gabapentin inhibits the interaction between α~2~δ-1 and thrombospondins, and therefore inhibits synaptogenesis ([@b0155]). Although this might be considered a plausible mechanism of action of gabapentinoid drugs in treatment of epilepsies, synaptic remodeling that occurs at epileptic foci ([@b0255]) is likely to have already occurred before the onset of treatment with these drugs. Nevertheless, it is possible that the gabapentinoid drugs may also modify epileptogenesis and decrease the consequences of status epilepticus by reducing cellular damage and seizure frequency ([@b0110; @b0265]).
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![Comparison between hippocampi from kainic acid-treated and control rats. (A, B) Cresyl Violet (cv) staining of a representative hippocampal section from a kainate-treated rat (A, rat \#2) and a saline control rat (B, rat \#16). Arrows indicate cell loss in A. (C, D) Composite image of NeuN immunostaining of a representative hippocampal section from a kainate-treated rat (C, rat \#2) and a saline control rat (D, rat \#16). (E, F) Composite image of DAPI staining of a representative hippocampal section from a kainate-treated rat (E, rat \#2) and a saline control rat (F, rat \#16). (G, H) Composite image of OX42 staining in adjacent hippocampal sections from kainate-treated rat (G, rat \#2) or saline control rat (H, \#16). Scale bar = 1 mm for all panels.](gr1){#f0005}

![α~2~δ-1 immunostaining in kainic acid-treated rat hippocampus compared to control hippocampus. (A) Low power composite image of α~2~δ-1 immunostaining (upper panel) in saline control (rat \#6), compared with DAPI staining (lower panel). Scale bars = 1 mm. (B) Low power composite image of staining in hippocampus of a kainate-treated rat (\#11) for α~2~δ-1 (left, upper and lower panels are 150 μm apart), NeuN (right upper panel) and OX42 (right lower panel), showing patchy loss of α~2~δ-1 immunoreactivity, associated with regions of loss of CA1 pyramidal neurons, and up-regulation of OX42 immunoreactivity (arrows). The sections stained for NeuN and OX42 are consecutive to the upper left section stained for α~2~δ-1. Scale bars = 1 mm.](gr2){#f0010}

![Localized reduction of α~2~δ-1 in stratum radiatum CA1 in field associated with loss of pyramidal neurons in kainic acid-treated rats. (A, B) High power images of α~2~δ-1 (left panel), MAP2 (middle panel), DAPI (right panel) in sections of CA1 and dentate gyrus (DG) associated with neuronal loss. (A) Shows reduced α~2~δ-1 immunoreactivity in localized areas (asterisks) where dentritic branches are absent, shown by loss of MAP2 immunoreactivity, and DAPI staining shows glial proliferation around the site of pyramidal neuron death. (B) Shows a section 1.2 mm rostral to the damaged area, as a control. *Abbreviations:* St.Ori = stratum oriens, St.pyr = stratum pyramidale, St.rad = stratum radiatum, fis = hippocampal fissure, St.ml = molecular layer, St.gl = granule cell layer. Scale bars = 100 μm.](gr3){#f0015}

![α~2~δ-1 staining in the stratum lucidum remains unaffected by neuronal cell loss in CA3 stratum pyramidale. (A, B) High power images of α~2~δ-1 (left panel), DAPI (middle panel), and MAP2 (right panel), in two example sections of the CA3 region of hippocampus from two kainate-treated rats (Ai, \#4 and Aii, \#13) and a saline-treated rat (B, \#6). For clarity the stratum lucidum is delimited by a solid line and the stratum pyramidale by a dashed line, or dotted line in areas of neuronal cell loss. *Abbreviations:* St.luc = stratum lucidum, St.pyr = stratum pyramidale, St.ori = stratum oriens. Scale bar = 100 μm.](gr4){#f0020}

![Histological examination of tetanus toxin-injected rat hippocampus, compared to saline-injected control. (A) Low power composite images in the hippocampus of a tetanus toxin-treated rat (TTX7), of α~2~δ-1 immunostaining (top panel) showing a localized area of reduced α~2~δ-1 staining (arrow), DAPI staining (middle panel, same section as top panel) showing pyramidal cell layer disruption due to injection track (arrow), and OX42 staining (bottom panel) from a section 175 μm away from that shown in upper and middle panels, showing microglial activation around injection site (arrow) and also a small amount along the stratum pyramidale of CA1 of the non-injected side (arrowheads). Scale bars = 1 mm. (B) Low power composite images of OX42 immunostaining and DAPI staining in the hippocampus (left and right panels, respectively) around the injection track of a saline-injected rat (Sal3). Scale bars = 0.5 mm.](gr5){#f0025}

![α~2~δ-1 up-regulation following SNL in rat DRGs and their projections, and in motor neurons. (A) Diagram of the SNL model used to induce mechanical hyperalgesia. Ipsilateral ligation (ligature, left) of the spinal nerve at the level of L5 (and L6, not shown) affects DRG neurons and their afferent projections innervating the dorsal horn of the spinal cord. Black circles indicate the location of DRG cell bodies, small black stars indicate motor neuron cell bodies. (B--E) Representative α~2~δ-1 immunofluorescence images of L6 DRG section (B and C, ipsi- and contralateral respectively) and dorsal root section (D and E, ipsi- and contralateral respectively), 14 days after SNL. α~2~δ-1 is upregulated in the ipsilateral DRG neurons of all sizes and also in their projections (green: α~2~δ-1, blue: DAPI). Scale bars = 20 μm. (F) Montage of α~2~δ-1 immunoperoxidase-stained microphotographs covering a complete L5 spinal cord section 14 days after SNL. α~2~δ-1 immunoreactivity is increased ipsilaterally, in the dorsal horn (dh), the fasciculus gracilis (fg), and in the cell bodies of motor neurons of the ventral side compared to the contralateral side. White dashed boxes indicate areas shown in G and H. Diamond (♦) marks a hole in the tissue introduced to identify the contralateral site. Scale bar = 200 μm. Fi: Insert shows the absence of staining when the primary antibody was omitted. (G, H) Higher power images of the ventral spinal cord, ipsilateral (G) and contralateral (H) to SNL, showing increased α~2~δ-1 immunostaining in motor neurons on the ipsilateral side (e.g. white arrows in G), Scale bars = 50 μm. The data for the figure were obtained during the course of our previous study ([@b0025]), but the images were not included in that study.](gr6){#f0030}

###### 

Kainic acid study: summary of animals used and histological analysis

  ID                                     Treatment     Status Epilepticus   Hippocampal damage (Cresyl Violet)   Microglia activation (OX42)   Hippocampal neuronal cell loss (NeuN)   Disruption of α~2~δ-1 staining in areas of neuronal cell loss   Ectopic α~2~δ-1 staining in CA3
  -------------------------------------- ------------- -------------------- ------------------------------------ ----------------------------- --------------------------------------- --------------------------------------------------------------- ---------------------------------
  1                                      Kainic acid   Yes                  CA1 (bi) + CA3 (bi)                  ND                            ND                                      No                                                              No
  2                                      Kainic acid   Yes                  CA1 (bi) + CA3 (bi)                  Yes                           Yes                                     Yes (CA1)                                                       No
  3                                      Kainic acid   Yes                  CA3 (bi)                             ND                            ND                                      No                                                              No
  4                                      Kainic acid   No                   CA1 (bi) + CA3 (bi)                  Yes                           Yes                                     No                                                              ++
  5                                      Kainic acid   Yes                  CA1 + CA3 (bi)                       ND                            ND                                      No                                                              No
  9[⁎](#tblfn1){ref-type="table-fn"}     Kainic acid   Yes                  CA1 + CA3 (bi)                       Yes                           Yes                                     Yes (CA1)                                                       ++
  10                                     Kainic acid   Yes                  CA3 (bi)                             ND                            ND                                      No                                                              No
  11                                     Kainic acid   Yes                  CA1 + CA3 (bi)                       Yes                           Yes                                     Yes (CA1)                                                       No
  12                                     Kainic acid   No                   No                                   No                            No                                      No                                                              No
  13                                     Kainic acid   Yes                  CA1 (bi) + CA3 (bi)                  Yes                           Yes                                     Yes (CA1)                                                       \+
                                                                                                                                                                                                                                                       
  6                                      Saline        No                   No                                   ND                            ND                                      No                                                              No
  7                                      Saline        No                   No                                   No                            No                                      No                                                              No
  8                                      Saline        No                   No                                   ND                            ND                                      ND                                                              ND
  14[⁎⁎](#tblfn2){ref-type="table-fn"}   Saline        No                   No                                   ND                            ND                                      ND                                                              ND
  15                                     Saline        No                   No                                   No                            No                                      No                                                              ++
  16                                     Saline        No                   No                                   No                            No                                      No                                                              No

Summary of all rats used in the kainic acid study, their treatment and histological analysis. Cresyl Violet staining was performed in the first slide of each series (equivalent to at least 8 slides per animal) for all brains. The presence of neuronal cell death was detected in the pyramidal cell layers of CA1 and/or CA3, as stated. In most cases the damage appeared bilaterally (bi). In the kainic acid-treated rats, sections adjacent to those Cresyl Violet stained sections showing hippocampal damage were also stained for α~2~δ-1, OX42 and NeuN, in a subset of rats. ND = not determined. +: staining present; ++: strong staining.

Sample with rostral side of right hippocampus deformed.

Sample not well-perfused.

###### 

Tetanus toxin study: summary of animals used and histological analysis

  ID     Treatment       Status epilepticus   Spontaneous seizures   Hippocampal damage near injection site (DAPI)   Microglia activation near injection site (OX42)   Microglia activation contralateral to injection site (OX42)   Disruption of α~2~δ-1 staining in areas of neuronal damage
  ------ --------------- -------------------- ---------------------- ----------------------------------------------- ------------------------------------------------- ------------------------------------------------------------- ------------------------------------------------------------
  TTX4   Tetanus toxin   No                   Yes (early onset)      DG + CA1                                        CA1                                               No                                                            No
  TTX5   Tetanus toxin   No                   Yes (infrequent)       CA1                                             CA1                                               No                                                            CA1
  TTX7   Tetanus toxin   No                   Yes (late onset)       CA1                                             CA1                                               \+                                                            CA1
  TTX8   Tetanus toxin   No                   No                     DG                                              CA1 + DG                                          No                                                            No
                                                                                                                                                                                                                                     
  Sal1   Saline          No                   No                     CA1 + DG                                        CA1                                               No                                                            No
  Sal2   Saline          No                   No                     CA1                                             CA1 + DG                                          No                                                            CA1
  Sal3   Saline          No                   No                     CA1 + DG                                        CA1 + DG                                          No                                                            No
  Sal4   Saline          No                   No                     CA1                                             No                                                No                                                            No

Summary of rats used in the tetanus toxin study, their treatment and histological analysis.
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